CurrentEndo
Get Weekly

Topic · page 67 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 2,641–2,680 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. J Clin Endocrinol Metab

    Sex Differences in “Life’s Essential 8” Cardiovascular Health and Type 2 Diabetes Mellitus Risk Across Menopause Stages

    Cohort study

  2. Diabetes Obes Metab

    Periodontal tissue susceptibility to glycaemic control in type 2 diabetes

    Cohort study

  3. Diabetes Obes Metab

    Metformin in the Diabetes Prevention Program 3‐year trial: The cost‐effectiveness that never was

    Research article

  4. Diabetes Res Clin Pract

    Effects on calcium phosphate homeostasis after sodium-glucose cotransporter 2 inhibitor in patients with advanced chronic kidney disease and type 2 diabetes mellitus

    Cohort study

  5. J Clin Endocrinol Metab

    Deficiency of Peptidylglycine-alpha-amidating Monooxygenase, a Cause of Sarcopenic Diabetes Mellitus

    Cohort study

  6. Diabetes Care

    Discrepancy Between Genetically Predicted and Observed BMI Predicts Incident Type 2 Diabetes

    Cohort study

  7. Diabetes Care

    Comprehensive Multiple Risk Factor Control in Type 2 Diabetes to Mitigate Heart Failure Risk: Insights From a Prospective Cohort Study

    Cohort study

  8. Diabetes Res Clin Pract

    Glucose lowering drug or strategy dependent impact of weight reduction on the prevention of CVD outcomes in Type 2 diabetes: a systematic review of CVOTs

    Meta-analysis

  9. Diabetologia

    Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes

    Secondary analysis

  10. Diabetes Technol Ther

    Beyond Glucose Monitoring: Multianalyte Sensor Use in Diabetes

    Research article

  11. Diabetes Obes Metab

    Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study

    Cohort study

  12. Diabetes Obes Metab

    Sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors on major liver outcomes in metabolic dysfunction‐associated steatotic liver disease

    Cohort study

  13. Diabetes Obes Metab

    The effect of Mankai plant consumption on postprandial glycaemic response among patients with type 2 diabetes: A randomized crossover trial

    Randomized controlled trial

  14. Int J Obes (Lond)

    The rs2341471-G/G genotype of activating transcription factor 6 (ATF6) is the risk factor of type 2 diabetes in subjects with obesity or overweight

    Case-control study

  15. Cardiovasc Diabetol

    Detecting heart stress using NT-proBNP in patients with type 2 diabetes mellitus and hypertension or high-normal blood pressure: a cross-sectional multicentric study

    Cross-sectional study

  16. J Clin Endocrinol Metab

    β-Cell Dedifferentiation in HOMA-βlow and HOMA-βhigh Subjects

    Mechanistic study

  17. Cardiovasc Diabetol

    Compromised cardiac autonomic function in non-diabetic subjects with 1 h post-load hyperglycemia: a cross-sectional study

    Cross-sectional study

  18. Diabetes Res Clin Pract

    Association between temperatures and type 2 diabetes: A prospective study in UK Biobank

    Cohort study

  19. Diabetes Care

    Economic Costs Attributed to Diagnosed Diabetes in Each U.S. State and the District of Columbia: 2021

    Research article

  20. Diabetes Obes Metab

    Cystic fibrosis‐related diabetes develops from a combination of insulin secretion defects and insulin resistance

    Cohort study

  21. Diabetes Metab

    Association between gastrectomy and the risk of type 2 diabetes in gastric cancer survivors: A nationwide cohort study

    Cohort study

  22. Diabetes Obes Metab

    Real‐world safety profile of once‐weekly semaglutide in people with type 2 diabetes: Analysis of pooled data from the SemaglUtide Real‐world Evidence (SURE) programme

    Meta-analysis

  23. Diabetes Obes Metab

    Oxytocin does not acutely improve glucose tolerance in men with type 2 diabetes

    Randomized controlled trial

  24. Cardiovasc Diabetol

    The right ventricular dysfunction and ventricular interdependence in patients with T2DM and aortic regurgitation: an assessment using CMR feature tracking

    Cross-sectional study

  25. Diabetes Res Clin Pract

    β-cell function and long-term glycemic control in patients newly diagnosed with type 2 diabetes with moderate hyperglycemia after a 6-month course of basal insulin therapy

    Randomized controlled trial

  26. Cardiovasc Diabetol

    The impact of diabetes mellitus on cardiac function assessed by magnetic resonance imaging in patients with hypertrophic cardiomyopathy

    Case-control study

  27. BMJ Open Diabetes Res Care

    Real-world study of the multimorbidity and health service utilisation among individuals with non-diabetic hyperglycemia and type 2 diabetes mellitus in North West London

    Cohort study

  28. Diabet Med

    Very‐low‐calorie diet‐based intensive lifestyle intervention for remission of type 2 diabetes: Real‐world experience in a South Asian population

    Cohort study

  29. J Clin Endocrinol Metab

    Pre-Prediabetes: Insulin Resistance Is Associated With Cardiometabolic Risk in Nonobese Patients (STOP DIABETES)

    Cross-sectional study

  30. Cardiovasc Diabetol

    Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial

    Secondary analysis

  31. Cardiovasc Diabetol

    Physical activity modification following a Transient Ischemic Attack in individuals with diabetes

    Cohort study

  32. Cardiovasc Diabetol

    Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

    Cohort study

  33. Diabetes Obes Metab

    Dark tea consumption is associated with a reduced risk of dysglycaemia and increased urinary glucose and sodium excretion in Chinese adults

    Cross-sectional study

  34. Diabetes Obes Metab

    Comparing the effectiveness of molnupiravir and nirmatrelvir‐ritonavir in non‐hospitalized and hospitalized COVID ‐19 patients with type 2 diabetes: A target trial emulation study

    Research article

  35. Diabetes Obes Metab

    Efficacy, adherence and persistence of various glucagon‐like peptide‐1 agonists: nationwide real‐life data

    Cohort study

  36. Diabetes Obes Metab

    Sodium–glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real‐world, cohort data

    Cohort study

  37. J Clin Endocrinol Metab

    Insulin Sensitivity and Insulin Secretion in Adults With Friedreich's Ataxia: The Role of Skeletal Muscle

    Case-control study

  38. Diabetes Obes Metab

    Real‐world impact of adding a glucagon‐like peptide‐1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium‐glucose co‐transporter‐2 inhibitor: The Impact GLP‐1 CKD study

    Cohort study

  39. BMJ Open Diabetes Res Care

    Risk of healthcare visits from influenza in subjects with diabetes and impacts of early vaccination

    Cohort study

  40. Diabetologia

    Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 2,641–2,680 of 4,758, newest first